We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).AuthorsKetterer, N.; Coiffier, B.; Thieblemont, C.; Fermé, C.; Brière, J.; Casasnovas, O.; Bologna, S.; Christian, B.; Connerotte, T.; Récher, C.; Bordessoule, D.; Fruchart, C.; Delarue, R.; Bonnet, C.; Morschhauser, F.; Anglaret, B.; Soussain, C.; Fabiani, B.; Tilly, H.; Haioun, C.PublicationAnnals of Oncology, 2013, Vol 24, Issue 4, p1032ISSN0923-7534Publication typearticleDOI10.1093/annonc/mds600